A variety of preventive strategies for oral mucositis (OM) have been validated and recommended.[22]Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1;126(19):4423-31.
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33100
http://www.ncbi.nlm.nih.gov/pubmed/32786044?tool=bestpractice.com
Their use should be tailored to the cancer treatment regimen for each individual. For patients receiving bolus doses of chemotherapy drugs with a short half-life, such as fluorouracil and melphalan, the use of ice chips and/or ice-cold water as 'cryotherapy' can reduce the severity of OM.[23]Peterson DE, Ohrn K, Bowen J, et al. Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2013 Jan;21(1):327-32.
http://www.ncbi.nlm.nih.gov/pubmed/22993025?tool=bestpractice.com
This effect is thought to be mediated by a reduced delivery of the drug to the oral mucosa secondary to local vasoconstriction. Ice chips/iced water should be placed in the mouth, beginning 5 minutes before giving chemotherapy and replenished as needed for up to 30 minutes.[24]Peterson DE, Boers-Doets CB, Bensadoun RJ, et al; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015 Sep;26(suppl 5):v139-51.
https://www.annalsofoncology.org/article/S0923-7534(19)47173-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26142468?tool=bestpractice.com
[25]Riley P, Glenny AM, Worthington HV, et al. Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev. 2015 Dec 23;(12):CD011552.
https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011552.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/26695736?tool=bestpractice.com
Palifermin (recombinant keratinocyte growth factor) may be used to decrease the incidence and duration of severe OM in patients with haemotological malignancies receiving high-dose chemotherapy and total body irradiation followed by autologous stem cell transplantation (SCT).[24]Peterson DE, Boers-Doets CB, Bensadoun RJ, et al; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015 Sep;26(suppl 5):v139-51.
https://www.annalsofoncology.org/article/S0923-7534(19)47173-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26142468?tool=bestpractice.com
If indicated, palifermin is administered intravenously for 3 consecutive days before and 3 consecutive days after chemoradiation. Palifermin may not be available in some countries.
Maintenance of good oral hygiene can reduce the severity of OM in patients receiving chemotherapy.[26]de Lima Martins JO, Carlos ACAM, Costa GAJ, et al. Oral hygiene protocols reduce the severity and incidence of oral mucositis during antineoplastic treatment: a systematic review and meta-analysis of randomized and non-randomized clinical trials. Support Care Cancer. 2023 Jul 21;31(8):480.
http://www.ncbi.nlm.nih.gov/pubmed/37477721?tool=bestpractice.com
Appropriate dental care before the onset of treatment, and the use of oral care protocols during treatment, may be useful preventive strategies.[24]Peterson DE, Boers-Doets CB, Bensadoun RJ, et al; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015 Sep;26(suppl 5):v139-51.
https://www.annalsofoncology.org/article/S0923-7534(19)47173-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26142468?tool=bestpractice.com
[27]McGuire DB, Fulton JS, Park J, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Nov;21(11):3165-77.
http://www.ncbi.nlm.nih.gov/pubmed/24018908?tool=bestpractice.com
Oral care should include the use of a soft toothbrush that is replaced regularly.
In patients with metal dental restorations, the use of devices such as a dental guard, cotton roll, or wax to separate the metal from the mucosa can prevent adjacent mucositis due to radiation backscatter.[28]Tso TV, Hurwitz M, Margalit DN, et al. Radiation dose enhancement associated with contemporary dental materials. J Prosthet Dent. 2019 Apr;121(4):703-7.
http://www.ncbi.nlm.nih.gov/pubmed/30580980?tool=bestpractice.com
Patients receiving high-dose chemotherapy or chemoradiation before haematopoietic SCT, and patients receiving head and neck radiotherapy without concomitant chemotherapy, may benefit from low-level laser therapy to reduce the severity of OM.[22]Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1;126(19):4423-31.
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33100
http://www.ncbi.nlm.nih.gov/pubmed/32786044?tool=bestpractice.com
[24]Peterson DE, Boers-Doets CB, Bensadoun RJ, et al; ESMO Guidelines Committee. Management of oral and gastrointestinal mucosal injury: ESMO clinical practice guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 2015 Sep;26(suppl 5):v139-51.
https://www.annalsofoncology.org/article/S0923-7534(19)47173-1/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/26142468?tool=bestpractice.com
[29]Migliorati C, Hewson I, Lalla RV, et al. Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Jan;21(1):333-41.
http://www.ncbi.nlm.nih.gov/pubmed/23001179?tool=bestpractice.com
The mechanism of action is not well understood, but is thought to be via promotion of healing and anti-inflammatory effects.[30]Lopes NN, Plapler H, Chavantes MC, et al. Cyclooxygenase-2 and vascular endothelial growth factor expression in 5-fluorouracil-induced oral mucositis in hamsters: evaluation of two low-intensity laser protocols. Support Care Cancer. 2009 Nov;17(11):1409-15.
http://www.ncbi.nlm.nih.gov/pubmed/19234862?tool=bestpractice.com
[31]Lopes NN, Plapler H, Lalla RV, et al. Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. Lasers Surg Med. 2010 Aug;42(6):546-52.
http://www.ncbi.nlm.nih.gov/pubmed/20662031?tool=bestpractice.com
The Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology recommends following specific photobiomodulation protocols for optimal response.[22]Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1;126(19):4423-31.
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33100
http://www.ncbi.nlm.nih.gov/pubmed/32786044?tool=bestpractice.com
An anti-inflammatory mouthwash may help reduce mucositis severity in patients receiving head and neck radiotherapy with or without concomitant chemotherapy.[22]Elad S, Cheng KKF, Lalla RV, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020 Oct 1;126(19):4423-31.
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.33100
http://www.ncbi.nlm.nih.gov/pubmed/32786044?tool=bestpractice.com
[32]Nicolatou-Galitis O, Sarri T, Bowen J, et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer. 2013 Nov;21(11):3179-89.
http://www.ncbi.nlm.nih.gov/pubmed/23702538?tool=bestpractice.com
All patients at risk of OM require a baseline oral and dental assessment.[33]UK Oral Management in Cancer Care Group. Oral Care guidance and support in cancer and palliative care. Jun 2019 [internet publication].
http://www.ukomic.com/guidance.html